BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2776253)

  • 81. PHYSICAL PROPERTIES OF HUMAN GYNECOLOGICAL TUMORS: MICRURGICAL AND CENTRIFUGATION STUDIES ON LIVING CELLS.
    MATEYKO GM; KOPAC MJ
    Prog Exp Tumor Res; 1964; 4():27-56. PubMed ID: 14150249
    [No Abstract]   [Full Text] [Related]  

  • 82. C-myc oncogene product p62 in ovarian mucinous neoplasms.
    Loke SL; Leung CY; Lo YM
    J Clin Pathol; 1990 Jan; 43(1):85-6. PubMed ID: 2138167
    [No Abstract]   [Full Text] [Related]  

  • 83. [Clinical composition of patients and treatment of primary ovarian neoplasms at the Institute of Oncology in Warsaw in the years 1958-1964].
    Piatkowski Z; Jentys W
    Nowotwory; 1971; 21(2):133-9. PubMed ID: 5570896
    [No Abstract]   [Full Text] [Related]  

  • 84. A feasibility study in the development of biological markers for ovarian cancer.
    Waalkes TP; Rosenshein NB; Shaper JH; Ettinger DS; Woo KB; Paone JF; Gehrke CW
    J Surg Oncol; 1982 Dec; 21(4):207-14. PubMed ID: 6815381
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A papillary cystadenocarcinoma of the ovary with peritoneal metastases diagnosed radiologically.
    Andrees MR
    Br J Radiol; 1970 Feb; 43(506):143-6. PubMed ID: 5424282
    [No Abstract]   [Full Text] [Related]  

  • 86. Spontaneous papillary cystadenocarcinoma of the ovary in Dunkin-Hartley guineapigs.
    Hong CC
    Lab Anim; 1980 Jan; 14(1):39-40. PubMed ID: 7359885
    [No Abstract]   [Full Text] [Related]  

  • 87. A Rare Case of Low-Grade Serous Cystadenocarcinoma of the Ovary in a Seventeen-Year-Old Woman.
    Rickards J; Brooks BA; Rivera-Betancourt A; Velasquez D
    Cureus; 2022 Aug; 14(8):e28086. PubMed ID: 36128000
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Association of a 97 kilodalton glycoprotein with human ovarian carcinoma.
    Rao GS; Hanjani P
    Cancer Lett; 1985 Apr; 26(3):327-34. PubMed ID: 3995504
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Evaluation of the Potential Diagnostic Utility of the Determination of Selected Caspases-Markers Involved in the Regulation of Apoptosis-In Patients with Ovarian Cancer.
    Mielczarek-Palacz A; Jasińska S; Strzelec A
    Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33919909
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Quantitative detection of lectin receptors on cell membranes using an enzyme linked lectin binding assay.
    Martinod SR
    Prep Biochem; 1985; 15(3):171-81. PubMed ID: 2865724
    [No Abstract]   [Full Text] [Related]  

  • 91. Changing trends in the incidence of ovarian neoplasia and its relationship with the risk factors: a report of 311 cases from north-eastern anatolia region.
    Demirci E; Daloglu FT; Calik M; Altun E; Sipal S; Borekci B
    Eurasian J Med; 2015 Feb; 47(1):48-55. PubMed ID: 25745345
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Spontaneous rupture of ovarian cystadenocarcinoma: pre- and post-rupture computed tomography evaluation.
    Salvadori PS; Bomfim LN; von Atzingen AC; D'Ippolito G
    Radiol Bras; 2015; 48(5):330-2. PubMed ID: 26543286
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Heterologous growth of ovarian cancer.
    TOVELL HM; BLACKWOOD C; MANDL I; TAYLOR HC
    Am J Obstet Gynecol; 1963 Jan; 85():74-84. PubMed ID: 13993868
    [No Abstract]   [Full Text] [Related]  

  • 94. THE FIGURATE ERYTHEMAS AND NEOPLASIA.
    SUMMERLY R
    Br J Dermatol; 1964; 76():370-3. PubMed ID: 14201186
    [No Abstract]   [Full Text] [Related]  

  • 95. Giant ovarian mucinous cystadenocarcinoma: A case report.
    Shrestha BM; Shrestha S; Kharel S; Aryal S; Rauniyar R; Kuikel S; Tiwari SB; Chaurasia H; Chapagain S; Shrestha P
    Clin Case Rep; 2022 Jul; 10(7):e6067. PubMed ID: 35846900
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Right Ovarian Mucinous Cystadenoma Coexisting with an Incidental Left Ovarian Haemangioma in a Postmenopausal Patient.
    Altınay S; Naki MM; Toksöz M; Albayrak R
    West Indian Med J; 2014 Dec; 63(7):812-4. PubMed ID: 25867576
    [No Abstract]   [Full Text] [Related]  

  • 97. Retraction. LMX1A as a prognostic marker in ovarian mucinous cystadenocarcinoma.
    Am J Clin Pathol; 2012 Jul; 138(1):167. PubMed ID: 22706874
    [No Abstract]   [Full Text] [Related]  

  • 98. Mistakes in the diagnosis of cancer.
    SALTZSTEIN HC; RAO JO; YARED JA
    Am J Surg; 1949 Jul; 78(1):113-22. PubMed ID: 18152998
    [No Abstract]   [Full Text] [Related]  

  • 99. [Renal cystadenoma].
    AMSELEM A; RABADAN MARINA M
    Rev Clin Esp; 1950 May; 37(3):197-200. PubMed ID: 15430730
    [No Abstract]   [Full Text] [Related]  

  • 100. Ovarian cancer during fertility follow-up.
    Jiménez A; Chiva L
    Int J Gynecol Cancer; 2024 Mar; ():. PubMed ID: 38531537
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.